取消药品加成对上海市尿毒症患者大病门诊费用的影响

Effects of Abolishing Drug Addition on Outpatients’ Expenses of Major Diseases for Patients with Uremia in Shanghai

目的探讨取消药品加成政策对上海市尿毒症患者大病门诊费用的影响。方法收集上海市某三甲医院2014—2018年尿毒症患者在大病门诊发生的费用数据,整理后利用统计软件分析差异。结果1085位患者的人均总费用较取消药品加成前下降15.08%,其中人均药品费下降60.69%。结论该政策的实施,达到预期的效果,尿毒症患者的大病门诊费用明显降低。但此类重大疾病患者的医疗负担仍存在,建议从其他层面进一步帮助患者减轻经济压力。

Objective To explore the effects of the policy of abolishing drug addition on outpatients’ expenses of major diseases for patients with uremia in Shanghai. Methods The data on the expenses of uremia patients in the outpatient department of a tertiary hospital in Shanghai from 2014 to 2018 were collected, and the differences were analyzed by statistical software. Results The total annual per capita cost of the 1085 patients decreased by 15.08% compared with that before abolishing drug addition and among which the annual per capita drug cost decreased by 60.69%. Conclusion The implementation of the policy of abolishing drug addition can achieve the expected effects, and the outpatient cost of major diseases for uremia patients can be reduced significantly. However, the medical burden of patients with such critical illnesses still exists, and it is suggested to further relieve patients of financial pressure from other aspects.